CBD Global Sciences Inc.
OTC: CBDNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Brad Wyatt
- Headquarters
- Lakewood, United States
- IPO year
- 2021
- Market cap
- $2.1M
- Website
- https://www.cbdglobalsciences.com
Loading CBDNF…
Loading profile data…Frequently asked questions about CBDNF
What does CBD Global Sciences Inc. (CBDNF) do?
CBD Global Sciences Inc. operates within the cannabidiol (CBD) sector, handling the cultivation, processing, and manufacturing of CBD products. Its offerings include biomass, various CBD oils, and other CBD-based items, which are marketed under the Aethics, CannaOil, and Strasburg Pharms brands. Founded in 2018, the company's main offices are lo...
Where does CBDNF trade?
CBD Global Sciences Inc. (CBDNF) trades on the Other OTC.
What sector is CBDNF in?
CBD Global Sciences Inc. (CBDNF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of CBD Global Sciences Inc.?
Brad Wyatt is the chief executive officer of CBD Global Sciences Inc. (CBDNF).
Where is CBD Global Sciences Inc. headquartered?
CBD Global Sciences Inc. is headquartered in United States.
Does CBDNF pay a dividend?
CBD Global Sciences Inc. (CBDNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CBDNF go public?
CBD Global Sciences Inc. (CBDNF) completed its initial public offering in 2021.